2006Journal of Practical Diagnosis and TherapyRequires access

Comparative study on the effect of valsartan and benazepril on left ventricle thickening and myocardial fibrosis resulting from hypertension

WU Shulun

Open publisher page 0 citations

Abstract

Objective To study the effect of valsartan and benazepril on left ventricle thickening and myocardial fibrosis resulting from hypertension.Methods The hypertension patients with left ventricle thickening and myocardial fibrosis were treated by valsartan and benazepril respectively.The parameters of left ventricle and PCⅢ,HA,and AngⅡ were measured respectively.Results PCⅢ,HA and AngⅡ in hypertension group were significantly higher than those in control group,and NO in hypertension group was significantly lower than that in control group before treatment.SBP,DSP,AngⅡ,PCⅢ,HA,IVST,LVPW,LVDd,LVM,and LVMI in both groups after treatment were significantly lower than those before treatment(P0.05),and NO was significantly higher than that before treatment(P0.05).Conclusion Valsartan is as the same as benazepril to lower hypertension,inhibit left ventricle thickening and myocardial fibrosis.Valsartan has less adverse effect than benazepril.

About this research paper

What this paper is about

Objective To study the effect of valsartan and benazepril on left ventricle thickening and myocardial fibrosis resulting from hypertension.Methods The hypertension patients with left ventricle thickening and myocardial fibrosis were treated by valsartan and benazepril respectively.The parameters of left ventricle and PCⅢ,HA,and AngⅡ were measured respectively.Results PCⅢ,HA and AngⅡ in hypertension group were significantly higher than those in control group,and NO in hypertension group was significantly lower than that in control group before treatment.SBP,DSP,AngⅡ,PCⅢ,HA,IVST,LVPW,LVDd,LVM,and LVMI in both groups after treatment were significantly lower than those before treatment(P0.05),and NO was significantly higher than that before treatment(P0.05).Conclusion Valsartan is as the same as benazepril to lower hypertension,inhibit left ventricle thickening and myocardial fibrosis.Valsartan has less adverse effect than benazepril.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To study the effect of valsartan and benazepril on left ventricle thickening and myocardial fibrosis resulting from hypertension.Methods The hypertension patients with left ventricle thickening and myocardial fibrosis were treated by valsartan and benazepril respectively.The parameters of left ventricle and PCⅢ,HA,and AngⅡ were measured respectively.Results PCⅢ,HA and AngⅡ in hypertension group were significantly higher than those in control group,and NO in hypertension group was significantly lower than that in control group before treatment.SBP,DSP,AngⅡ,PCⅢ,HA,IVST,LVPW,LVDd,LVM,and LVMI in both groups after treatment were significantly lower than those before treatment(P0.05),and NO was significantly higher than that before treatment(P0.05).Conclusion Valsartan is as the same as benazepril to lower hypertension,inhibit left ventricle thickening and myocardial fibrosis.Valsartan has less adverse effect than benazepril.

Key concepts: Benazepril, Medicine, Ventricle, Valsartan, Internal medicine, Thickening, Cardiology, Fibrosis

Related papers

Back to paper searchBrowse research topicsOriginal source
Comparative study on the effect of valsartan and benazepril on left ventricle thickening and myocardial fibrosis resulting from hypertension — Research Paper | ScholarLens